Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
Cannabis products that contain the tetrahydrocannabinol (THC) cannabinoid are emerging as promising therapeutic agents for the treatment of medical conditions such as chronic pain. THC elicits psychoactive effects through modulation of dopaminergic neurons, thereby altering levels of dopamine in the...
Main Authors: | Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michaud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/10/1107 |
Similar Items
-
Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report
by: Selina Muhn, et al.
Published: (2022-06-01) -
Cannabis Pharmacogenomics: A Path to Personalized Medicine
by: Mariana Babayeva, et al.
Published: (2023-04-01) -
Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
by: Malavika Deodhar, et al.
Published: (2021-09-01) -
The Effect of Dopamine Antagonist Treatment on Auditory Verbal Hallucinations in Healthy Individuals Is Clearly Influenced by COMT Genotype and Accompanied by Corresponding Brain Structural and Functional Alterations: An Artificially Controlled Pilot Study
by: Chuanjun Zhuo, et al.
Published: (2019-03-01) -
Cannabis use and psychosis among patients hospitalized in psychiatric wards in Lebanon: a retrospective chart review
by: Pia Maria Ghanimé, et al.
Published: (2023-11-01)